Source 1primary paper2025MED
Toolkit/dengue enveloped viral-like particle vaccine prototype
dengue enveloped viral-like particle vaccine prototype
Also known as: dengue vaccine prototype, dengue viral-like particles, enveloped VLPs, eVLPs, VLPs
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
production of dengue viral-like particles (VLPs)... developing a novel purification platform for enveloped VLPs (eVLPs), and establishing alternative biophysical characterization methods for the dengue vaccine prototype
Usefulness & Problems
Why this is useful
This is the dengue vaccine prototype studied in the paper, described as dengue viral-like particles including enveloped VLPs. It is the central product being produced, purified, and characterized.; dengue vaccine development; process development for enveloped VLP manufacture
Source:
This is the dengue vaccine prototype studied in the paper, described as dengue viral-like particles including enveloped VLPs. It is the central product being produced, purified, and characterized.
Source:
dengue vaccine development
Source:
process development for enveloped VLP manufacture
Problem solved
It is intended as a dengue vaccine candidate that can be manufactured through an efficient and scalable process. The study focuses on making its production and characterization more practical.; serves as the vaccine prototype being produced, purified, and characterized in the study
Source:
It is intended as a dengue vaccine candidate that can be manufactured through an efficient and scalable process. The study focuses on making its production and characterization more practical.
Source:
serves as the vaccine prototype being produced, purified, and characterized in the study
Problem links
serves as the vaccine prototype being produced, purified, and characterized in the study
LiteratureIt is intended as a dengue vaccine candidate that can be manufactured through an efficient and scalable process. The study focuses on making its production and characterization more practical.
Source:
It is intended as a dengue vaccine candidate that can be manufactured through an efficient and scalable process. The study focuses on making its production and characterization more practical.
Published Workflows
Objective: Develop an alternative process development pathway for future manufacturing of a dengue vaccine in yeast, including production, culture optimization, purification, and biophysical characterization of enveloped VLPs.
Why it works: The abstract states that Komagataella phaffii combines the speed and ease of highly efficient prokaryotic platforms with some key capabilities of mammalian systems, making it ideal for scalable and cost-effective production.
production of dengue viral-like particles in Komagataella phaffiiDesign of Experiments optimizationsmall-scale bioreactor process developmentpurification platform developmentbiophysical characterization method development
Stages
- 1.Yeast production of dengue VLPs(functional_characterization)
This stage establishes that the yeast platform can produce the dengue VLP vaccine prototype before further process development steps.
Selection: Demonstration of the versatility of the Komagataella phaffii platform in production of dengue viral-like particles.
- 2.Culture process optimization in small-scale bioreactors(secondary_characterization)
This stage improves the culture process after production has been demonstrated, supporting a simplified and scalable manufacturing pathway.
Selection: Optimization of the culture process using Design of Experiments approaches in small-scale bioreactors.
- 3.Purification platform development for enveloped VLPs(secondary_characterization)
This stage addresses downstream processing needs for the eVLP product as part of the manufacturing process-development pathway.
Selection: Development of a novel purification platform for enveloped VLPs.
- 4.Biophysical characterization of the dengue vaccine prototype(confirmatory_validation)
This stage provides characterization methods to assess the vaccine prototype after production and purification development.
Selection: Establishment of alternative biophysical characterization methods for the dengue vaccine prototype.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A reusable architecture pattern for arranging parts into an engineered system.
Techniques
No technique tags yet.
Target processes
No target processes tagged yet.
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: actuator
The abstract indicates that it requires a yeast production host, culture-process optimization, a purification platform, and biophysical characterization methods. Specific construct components are not given in the provided evidence.; requires production in Komagataella phaffii; requires purification and biophysical characterization workflows
The abstract does not provide evidence about clinical efficacy, exact antigen design, or immunogenicity performance. Those details remain outside the provided evidence.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
The reported findings provide a promising foundation for efficient and scalable production of dengue vaccines.
The study developed a novel purification platform for enveloped viral-like particles.
The study established alternative biophysical characterization methods for the dengue vaccine prototype.
Komagataella phaffii was used as an alternative host platform for future dengue vaccine manufacturing.
The study demonstrated production of dengue viral-like particles using the Komagataella phaffii platform.
Approval Evidence
1 source3 linked approval claimsfirst-pass slug dengue-enveloped-viral-like-particle-vaccine-prototype
production of dengue viral-like particles (VLPs)... developing a novel purification platform for enveloped VLPs (eVLPs), and establishing alternative biophysical characterization methods for the dengue vaccine prototype
Source:
manufacturing promisesupports
The reported findings provide a promising foundation for efficient and scalable production of dengue vaccines.
Source:
method developmentsupports
The study established alternative biophysical characterization methods for the dengue vaccine prototype.
Source:
production demonstrationsupports
The study demonstrated production of dengue viral-like particles using the Komagataella phaffii platform.
Source:
Comparisons
Source-backed strengths
presented as compatible with efficient and scalable production workflows
Source:
presented as compatible with efficient and scalable production workflows
Ranked Citations